Physician
Oncology
Dr. Norman Coleman, MD
|
|
Give Review
Norman Coleman practices Oncology. He graduated from Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He received 1 awards: "Fellow (FASCO)". Doctor Norman Coleman, MD is a published doctor and has 24 publications published. The lastest was: 'Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.'
Publications
- Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.
- Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.
- A Roadmap for a New Academic Pathway for Global Radiation Oncology.
- Combining Targeted Agents With Modern Radiotherapy in Soft Tissue Sarcomas.
- Defining Molecular Signature of Pro-Immunogenic Radiotherapy Targets in Human Prostate Cancer Cells.
- The medical student perspective on global health care in radiation oncology: opportunities, barriers to sustainability, and future directions.
- Differential Expression of Stress and Immune Response Pathway Transcripts and miRNAs in Normal Human Endothelial Cells Subjected to Fractionated or Single-Dose Radiation.
- Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.
- Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.
- Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations.
- Harnessing the potential of radiation-induced immune modulation for cancer therapy.
- Lessons learned from radiation oncology clinical trials.
- Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy.
- Radiation Survivors: Understanding and Exploiting the Phenotype following Fractionated Radiation Therapy.
- Fukushima and the Future of Radiation Research.
- Fractionated Radiation Alters Oncomir and Tumor Suppressor miRNAs in Human Prostate Cancer Cells.
- Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity by Small Molecule GMX1778 Regulates Reactive Oxygen Species (ROS)-mediated Cytotoxicity in a p53-...
- Normal tissue protection for improving radiotherapy: Where are the Gaps?
- mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.
- The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.
- National Cancer Institute's Cancer Disparities Research Partnership Program: Experience and Lessons Learned.
- Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems.
- First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation.
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Fellow (FASCO)
Education
-
Stanford University -
UCSF -
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Kieron M. Dunleavy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrian M. Senderowicz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Daniel B. Rubinstein, MD |
|
|
Dr. Ronald E. Gress, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jaye L. Viner, MD
This Doctor is OpenDoctor Recommended.
|